Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Capital Reinvestment Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.84 Billion) in capital expenditures (CN¥330.65 Million). See Guangzhou Baiyunshan Pharmaceutical Hold net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Check Guangzhou Baiyunshan Pharmaceutical Hold (600332) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. For live market cap and broader valuation context, see Guangzhou Baiyunshan Pharmaceutical Hold stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.76x | CN¥260.23 Million | CN¥1.24 Billion | ▲ +1353.9% |
| 2024 | 0.33x | CN¥3.44 Billion | CN¥1.13 Billion | ▼ -17.4% |
| 2023 | 0.40x | CN¥4.10 Billion | CN¥1.63 Billion | ▲ +100.7% |
| 2022 | 0.20x | CN¥7.00 Billion | CN¥1.38 Billion | ▼ -10.6% |
| 2021 | 0.22x | CN¥5.67 Billion | CN¥1.25 Billion | ▼ -85.2% |
| 2020 | 1.50x | CN¥585.19 Million | CN¥876.50 Million | ▲ +213.5% |
| 2019 | 0.48x | CN¥5.02 Billion | CN¥2.40 Billion | ▲ +420.8% |
| 2018 | 0.09x | CN¥5.22 Billion | CN¥478.62 Million | ▼ -14.5% |
| 2017 | 0.11x | CN¥1.83 Billion | CN¥196.77 Million | ▲ +15.0% |
| 2016 | 0.09x | CN¥2.44 Billion | CN¥228.03 Million | ▼ -64.9% |
| 2015 | 0.27x | CN¥1.94 Billion | CN¥515.34 Million | ▲ +32.2% |
| 2014 | 0.20x | CN¥1.76 Billion | CN¥353.65 Million | ▼ -23.3% |
| 2013 | 0.26x | CN¥1.34 Billion | CN¥350.35 Million | ▲ +151.9% |
| 2012 | 0.10x | CN¥506.53 Million | CN¥52.61 Million | ▼ -90.9% |
| 2010 | 1.14x | CN¥73.17 Million | CN¥83.20 Million | ▲ +470.6% |
| 2009 | 0.20x | CN¥439.39 Million | CN¥87.56 Million | ▼ -99.0% |
| 2008 | 20.80x | CN¥6.10 Million | CN¥126.98 Million | ▲ +6271.7% |
| 2007 | 0.33x | CN¥375.74 Million | CN¥122.69 Million | ▼ -86.0% |
| 2006 | 2.33x | CN¥38.88 Million | CN¥90.45 Million | ▲ +173.7% |
| 2005 | 0.85x | CN¥146.32 Million | CN¥124.36 Million | ▼ -44.8% |
| 2004 | 1.54x | CN¥200.54 Million | CN¥308.69 Million | ▲ +49.8% |
| 2002 | 1.03x | CN¥169.01 Million | CN¥173.70 Million | ▼ -10.2% |
| 2001 | 1.14x | CN¥140.15 Million | CN¥160.44 Million | ▲ +100.9% |
| 2000 | 0.57x | CN¥286.95 Million | CN¥163.53 Million | — |